Connectyx

Curative Biotechnology Inc. is a pioneering company based in Palm City, FL, focused on identifying, acquiring, and developing disease-modifying therapeutic drug candidates, particularly in the realm of rare diseases. Their innovative business model and extensive industry expertise enable the development of first-in-class drugs with accelerated pathways to address the unmet medical needs of patients.

The company's current pipeline includes therapeutic assets in degenerative eye disease, neuro-oncology, and infectious diseases, with a strategic emphasis on orphan indications. Curative Biotechnology aims to leverage the mechanisms of action of their drug candidates to potentially expand their applications to non-orphan indications in the future.

Generated from the website